A statistical signalling model for use in surveillance of adverse drug reaction data

DOI10.1080/02664769823287MaRDI QIDQ4266301zbMATH OpenOpenAlexFDO

Authors Eric M. Hillson, Charlotte A. McMillan, Jack H. Reeves

Publication date 27 April 2000

Published in Journal of Applied Statistics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/02664769823287

zbMATH Keywords

surveillanceadverse drug events

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Software, source code, etc. for problems pertaining to statistics (62-04)

Recommendations

• A likelihood ratio test based method for signal detection with application to FDA's drug safety data
• Active postmarketing drug surveillance for multiple adverse events
• Data mining of the Australian adverse drug reactions database: a comparison of Bayesian and other statistical indicators
• A study of speedier signal detection for serious adverse events
• Bayesian model selection in logistic regression for the detection of adverse drug reactions

Cited in

(5)

• Monitoring vaccine safety by studying temporal variation of adverse events using vaccine adverse event reporting system
• scientific article; zbMATH DE number 6513535 (Why is no real title available?)
• Statistical modelling for risk assessment in pharmacoepidemiology: The case-crossover method.
• A fuzzy derivative approach to classification of outcomes from the ADRAC database
• Evaluations of some Exponentially Weighted Moving Average methods

This page was built for publication: A statistical signalling model for use in surveillance of adverse drug reaction data

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4266301)